John L. Leguyader

Array ( [id] => 3555105 [patent_doc_number] => 05574143 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-11-12 [patent_title] => 'Ribozymes' [patent_app_type] => 1 [patent_app_number] => 8/195735 [patent_app_country] => US [patent_app_date] => 1994-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 38 [patent_no_of_words] => 11395 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/574/05574143.pdf [firstpage_image] =>[orig_patent_app_number] => 195735 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3557164 [patent_doc_number] => 05543508 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-08-06 [patent_title] => 'Ribozymes' [patent_app_type] => 1 [patent_app_number] => 8/195072 [patent_app_country] => US [patent_app_date] => 1994-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 38 [patent_no_of_words] => 11442 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/543/05543508.pdf [firstpage_image] =>[orig_patent_app_number] => 195072 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3874703 [patent_doc_number] => 05747335 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-05 [patent_title] => 'Ribozymes' [patent_app_type] => 1 [patent_app_number] => 8/195073 [patent_app_country] => US [patent_app_date] => 1994-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 38 [patent_no_of_words] => 11414 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/747/05747335.pdf [firstpage_image] =>[orig_patent_app_number] => 195073 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3848526 [patent_doc_number] => 05766942 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-16 [patent_title] => 'Ribozymes' [patent_app_type] => 1 [patent_app_number] => 8/198175 [patent_app_country] => US [patent_app_date] => 1994-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 38 [patent_no_of_words] => 11440 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/766/05766942.pdf [firstpage_image] =>[orig_patent_app_number] => 198175 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3655618 [patent_doc_number] => 05622854 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-22 [patent_title] => 'Method and reagent for inhibiting T-cell leukemia virus replication' [patent_app_type] => 1 [patent_app_number] => 8/192941 [patent_app_country] => US [patent_app_date] => 1994-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11534 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/622/05622854.pdf [firstpage_image] =>[orig_patent_app_number] => 192941 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3704685 [patent_doc_number] => 05654183 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-05 [patent_title] => 'Genetically engineered mammalian neural crest stem cells' [patent_app_type] => 1 [patent_app_number] => 8/188286 [patent_app_country] => US [patent_app_date] => 1994-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 62 [patent_no_of_words] => 18571 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/654/05654183.pdf [firstpage_image] =>[orig_patent_app_number] => 188286 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3459675 [patent_doc_number] => 05391490 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-02-21 [patent_title] => 'Ubiquitin-specific protease' [patent_app_type] => 1 [patent_app_number] => 8/186434 [patent_app_country] => US [patent_app_date] => 1994-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 14 [patent_no_of_words] => 6950 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/391/05391490.pdf [firstpage_image] =>[orig_patent_app_number] => 186434 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3799533 [patent_doc_number] => 05827935 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-27 [patent_title] => 'Chimeric tRNA.sup.lys -ribozyme molecules' [patent_app_type] => 1 [patent_app_number] => 8/185827 [patent_app_country] => US [patent_app_date] => 1994-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 1526 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/827/05827935.pdf [firstpage_image] =>[orig_patent_app_number] => 185827 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3597296 [patent_doc_number] => 05559007 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-09-24 [patent_title] => 'Bacterial shuttle vectors' [patent_app_type] => 1 [patent_app_number] => 8/186222 [patent_app_country] => US [patent_app_date] => 1994-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 14026 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/559/05559007.pdf [firstpage_image] =>[orig_patent_app_number] => 186222 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3632343 [patent_doc_number] => 05610054 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-03-11 [patent_title] => 'Enzymatic RNA molecule targeted against Hepatitis C virus' [patent_app_type] => 1 [patent_app_number] => 8/182968 [patent_app_country] => US [patent_app_date] => 1994-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 29130 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/610/05610054.pdf [firstpage_image] =>[orig_patent_app_number] => 182968 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3828644 [patent_doc_number] => 05783682 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-21 [patent_title] => 'Oligonucleotide mimics having nitrogen-containing linkages' [patent_app_type] => 1 [patent_app_number] => 8/180124 [patent_app_country] => US [patent_app_date] => 1994-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12223 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 423 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/783/05783682.pdf [firstpage_image] =>[orig_patent_app_number] => 180124 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3621280 [patent_doc_number] => 05641754 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-24 [patent_title] => 'Antisense oligonucleotide compositions for selectively killing cancer cells' [patent_app_type] => 1 [patent_app_number] => 8/179655 [patent_app_country] => US [patent_app_date] => 1994-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 7135 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/641/05641754.pdf [firstpage_image] =>[orig_patent_app_number] => 179655 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3834909 [patent_doc_number] => 05712384 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-27 [patent_title] => 'Ribozymes targeting retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs' [patent_app_type] => 1 [patent_app_number] => 8/178082 [patent_app_country] => US [patent_app_date] => 1994-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 12714 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/712/05712384.pdf [firstpage_image] =>[orig_patent_app_number] => 178082 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4128924 [patent_doc_number] => 06033884 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-07 [patent_title] => 'Nucleic acid transporter systems and methods of use' [patent_app_type] => 1 [patent_app_number] => 8/167641 [patent_app_country] => US [patent_app_date] => 1993-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 37 [patent_no_of_words] => 34003 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/033/06033884.pdf [firstpage_image] =>[orig_patent_app_number] => 167641 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3509208 [patent_doc_number] => 05587305 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-24 [patent_title] => 'Pasteurella haemolytica transformants' [patent_app_type] => 1 [patent_app_number] => 8/162392 [patent_app_country] => US [patent_app_date] => 1993-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 10 [patent_no_of_words] => 9811 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/587/05587305.pdf [firstpage_image] =>[orig_patent_app_number] => 162392 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3825312 [patent_doc_number] => 05759831 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-02 [patent_title] => 'DNA molecules and vectors regarding clavulanic acid biosynthesis enzymes' [patent_app_type] => 1 [patent_app_number] => 8/159950 [patent_app_country] => US [patent_app_date] => 1993-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 4641 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/759/05759831.pdf [firstpage_image] =>[orig_patent_app_number] => 159950 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3543149 [patent_doc_number] => 05554510 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-09-10 [patent_title] => 'Regulation of gene expression' [patent_app_type] => 1 [patent_app_number] => 8/161170 [patent_app_country] => US [patent_app_date] => 1993-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 4488 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 182 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/554/05554510.pdf [firstpage_image] =>[orig_patent_app_number] => 161170 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3657337 [patent_doc_number] => 05591624 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-01-07 [patent_title] => 'Retroviral packaging cell lines' [patent_app_type] => 1 [patent_app_number] => 8/156789 [patent_app_country] => US [patent_app_date] => 1993-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 13762 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/591/05591624.pdf [firstpage_image] =>[orig_patent_app_number] => 156789 [rel_patent_id] =>[rel_patent_doc_number] =>)